These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 11588122)
1. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. Savinainen JR; Järvinen T; Laine K; Laitinen JT Br J Pharmacol; 2001 Oct; 134(3):664-72. PubMed ID: 11588122 [TBL] [Abstract][Full Text] [Related]
2. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944 [TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390 [TBL] [Abstract][Full Text] [Related]
4. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Bisogno T; Berrendero F; Ambrosino G; Cebeira M; Ramos JA; Fernandez-Ruiz JJ; Di Marzo V Biochem Biophys Res Commun; 1999 Mar; 256(2):377-80. PubMed ID: 10079192 [TBL] [Abstract][Full Text] [Related]
5. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. Chiba T; Ueno S; Obara Y; Nakahata N J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165 [TBL] [Abstract][Full Text] [Related]
6. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors. Savinainen JR; Saario SM; Niemi R; Järvinen T; Laitinen JT Br J Pharmacol; 2003 Dec; 140(8):1451-9. PubMed ID: 14623770 [TBL] [Abstract][Full Text] [Related]
7. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Hillard CJ Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):3-18. PubMed ID: 10785538 [TBL] [Abstract][Full Text] [Related]
8. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Bisogno T; MacCarrone M; De Petrocellis L; Jarrahian A; Finazzi-Agrò A; Hillard C; Di Marzo V Eur J Biochem; 2001 Apr; 268(7):1982-9. PubMed ID: 11277920 [TBL] [Abstract][Full Text] [Related]
9. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Guo J; Ikeda SR Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245 [TBL] [Abstract][Full Text] [Related]
10. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. González S; Cascio MG; Fernández-Ruiz J; Fezza F; Di Marzo V; Ramos JA Brain Res; 2002 Nov; 954(1):73-81. PubMed ID: 12393235 [TBL] [Abstract][Full Text] [Related]
11. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Saario SM; Savinainen JR; Laitinen JT; Järvinen T; Niemi R Biochem Pharmacol; 2004 Apr; 67(7):1381-7. PubMed ID: 15013854 [TBL] [Abstract][Full Text] [Related]
12. Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. Viganò D; Grazia Cascio M; Rubino T; Fezza F; Vaccani A; Di Marzo V; Parolaro D Neuropsychopharmacology; 2003 Jun; 28(6):1160-7. PubMed ID: 12637958 [TBL] [Abstract][Full Text] [Related]
13. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Breivogel CS; Griffin G; Di Marzo V; Martin BR Mol Pharmacol; 2001 Jul; 60(1):155-63. PubMed ID: 11408610 [TBL] [Abstract][Full Text] [Related]
15. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432 [TBL] [Abstract][Full Text] [Related]
17. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice. Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970 [TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptors and their ligands. Pertwee RG; Ross RA Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030 [TBL] [Abstract][Full Text] [Related]
19. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. Darmani NA J Pharmacol Exp Ther; 2002 Jan; 300(1):34-42. PubMed ID: 11752094 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. Laine K; Järvinen K; Mechoulam R; Breuer A; Järvinen T Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3216-22. PubMed ID: 12356827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]